Our results suggest that the CCR5/CCL5-dependent Treg recruitment to inflammation site in patients with type 1 diabetes may be impaired; however, a larger group of patients needs to be assessed to confirm this observation. The gene discussed is CCL5; the disease is type 1 diabetes mellitus.